专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

31. 发明申请

WO2010092514A1 VACUUM CLEANER 审中-公开
标题翻译：吸尘器
公开(公告)号：WO2010092514A1
公开(公告)日：2010-08-19
申请号：PCT/IB2010/050531
申请日：2010-02-05
申请人： KONINKLIJKE PHILIPS ELECTRONICS N.V. , JIANG, Haifeng , WIERDA, Wiebe , WEI, Min , SHI, Yang
发明人： JIANG, Haifeng , WIERDA, Wiebe , WEI, Min , SHI, Yang
IPC分类号： A47L5/36 , A47L9/00 , A47L9/32
CPC分类号： A47L9/327 , A47L5/362 , A47L9/00
摘要： A vacuum cleaner, comprising a body, a pivotable dust cover and a pivotable lifting handle, wherein the lifting handle is pivotably connected to the dust cover, and wherein the dust cover is pivotably connected to the body of the vacuum cleaner.
摘要翻译：一种真空吸尘器，包括主体，可枢转防尘盖和可枢转提升手柄，其中提升手柄可枢转地连接到防尘罩，并且其中防尘盖可枢转地连接到真空吸尘器的主体。

32. 发明申请

WO2018049103A1 MEDICATION INJECTION DEVICE 审中-公开
标题翻译：药物注射装置
公开(公告)号：WO2018049103A1
公开(公告)日：2018-03-15
申请号：PCT/US2017/050598
申请日：2017-09-08
申请人： WEI, Min
发明人： WEI, Min
IPC分类号： A61M5/00 , A61M5/178 , A61M5/20 , A61M5/24 , A61M5/28 , A61M5/31 , A61M5/315
摘要： An injection device is provided herein comprising a container body for holding medication content having a distal end and a proximal end, the container body providing an outward flange at the distal end and a ledge at the proximal end; a piston placed at the proximal end of the container body for sealing and displacing medication content; a push rod placed inside the container body for moving the piston distally; and a connector providing an orifice for medication content delivery, placed at said distal end of said container body. The orifice in the connector provides medication content injection fluid pathway. With modification of the fundamental structure, a number of innovative device designs are created.
摘要翻译：本文提供了一种注射装置，其包括用于容纳药物内容物的容器主体，所述容器主体具有远端和近端，所述容器主体在远端处提供向外凸缘并且在近端提供凸缘; 放置在容器主体的近端处的活塞，用于密封和排出药物内容物; 放置在容器主体内用于向远侧移动活塞的推杆; 以及连接器，其设置在所述容器主体的所述远端处，用于输送药物内容物的孔口。连接器中的孔口提供药物内容物注入流体路径。通过修改基本结构，创建了许多创新的设备设计。

33. 发明申请

WO2016036600A1 AUTOMATIC INJECTION DEVICE WITH VARIABLE DOSING 审中-公开
标题翻译：自动注射装置与可变化的剂量
公开(公告)号：WO2016036600A1
公开(公告)日：2016-03-10
申请号：PCT/US2015/047477
申请日：2015-08-28
申请人： WEI, Min
发明人： WEI, Min
IPC分类号： A61M5/00
CPC分类号： A61M5/31593 , A61M5/31538 , A61M5/3155 , A61M5/31563 , A61M5/31571 , A61M5/3158 , A61M5/3202 , A61M5/3204 , A61M2005/2026 , A61M2005/206
摘要： A medication delivery device, for use with a container having a distal end and a needle being placed at the distal end of the container, including: a push rod which is movable with respect to at least a portion of the container; a resilient member configured to bias the push rod to move toward the distal end of the container; a releasable restraining means configured to releasably restrain the push rod in a locked state against the biasing of the resilient member; a means to adjust amount of movement of the push rod with respect to the container in order to deliver a predetermined dose of medication; and an activation means configured to release the releasable means. The means to adjust amount of movement of the push rod with respect to the container is bidirectional. The device can accommodate containers of different size or shape.
摘要翻译：一种药物输送装置，用于具有放置在容器的远端的远端和针的容器，包括：可相对于容器的至少一部分移动的推杆; 弹性构件，构造成偏压推杆朝向容器的远端移动; 可释放的限制装置，被配置为可释放地将所述推杆限制在锁定状态，以抵抗所述弹性构件的偏压; 调节推杆相对于容器的运动量以便递送预定剂量的药物的装置; 以及被配置为释放可释放装置的激活装置。调整推杆相对于容器的移动量的装置是双向的。该装置可容纳不同尺寸或形状的容器。

34. 发明申请

WO2020117610A1 APPARATUS FOR MANUFACTURING CELL THERAPY PRODUCT 审中-公开
公开(公告)号：WO2020117610A1
公开(公告)日：2020-06-11
申请号：PCT/US2019/063822
申请日：2019-11-28
申请人： WEI, Min
发明人： WEI, Min
IPC分类号： B01F7/00 , B01F7/16 , B01F9/00 , B01L1/02 , C12M1/00 , C12M1/26 , G01N1/02
摘要： A system and the method of use for processing a cell therapy product includes a centrifugation container and a rotor generating centrifugal field that extends to the centrifugation container. The centrifugation container has a substantially cylindrically shaped container body and a movable plunger rod. The container body contains cell suspension and the movable plunger rod is configured to have a mixing blade at the end of the movable plunger rod contacting the cell suspension in the container body. The mixing blade on the movable plunger rod generates mixing force applied to the cell suspension when the movable plunger rod is rotated around axis of the container body. The end of the movable plunger rod contacting the cell suspension is also movable in the container body along longitudinal direction of the container body when withdrawing and expelling fluid in and out of the centrifugation container body.

35. 发明申请

WO2014040250A1 METHOD AND APPARATUS FOR ANTENNA CALIBRATION 审中-公开
标题翻译：天线校准的方法和装置
公开(公告)号：WO2014040250A1
公开(公告)日：2014-03-20
申请号：PCT/CN2012/081324
申请日：2012-09-13
申请人： TELEFONAKTIEBOLAGET L M ERICSSON (PUBL) , CHEN, Jia , SU, Youping , WEI, Min
发明人： CHEN, Jia , SU, Youping , WEI, Min
IPC分类号： H04B7/04
CPC分类号： H04B1/48 , H01Q3/267 , H04B1/56 , H04B7/04 , H04B17/12 , H04B17/14 , H04B17/21
摘要： Method and apparatus for antenna calibration have been disclosed. A radio unit (510) is provided. The radio unit (510) may comprise: a plurality of transmit/receive (TX/RX) paths; a plurality of radio frequency (RF) ports (512) connected with the plurality of TX/RX paths; and a coupling unit (516), coupled with the plurality of TX/RX paths and configured to inject an uplink (UL) calibration signal (550) into at least one of the plurality of TX/RX paths and extract a downlink (DL) calibration signal (540) from at least one of the plurality of TX/RX paths. A normal TX/RX path may be reused both for antenna calibration and antenna supervision. Thus, a low cost hardware solution for antenna calibration is provided. An AIR base station (500) comprising such radio unit (510) is also provided.
摘要翻译：已经公开了用于天线校准的方法和装置。提供无线电单元（510）。无线电单元（510）可以包括：多个发送/接收（TX / RX）路径; 与所述多个TX / RX路径连接的多个射频（RF）端口（512）; 以及耦合单元（516），与所述多个TX / RX路径耦合并且被配置为将上行链路（UL）校准信号（550）注入到所述多个TX / RX路径中的至少一个中，并且提取下行链路（DL）来自多个TX / RX路径中的至少一个的校准信号（540）。正常的TX / RX路径可以重新用于天线校准和天线监控。因此，提供了用于天线校准的低成本硬件解决方案。还提供了包括这种无线电单元（510）的AIR基站（500）。

36. 发明申请

WO2008054508A2 STABLE NANOSIZED AMORPHOUS DRUG 审中-公开
标题翻译：稳定的纳米非晶药物
公开(公告)号：WO2008054508A2
公开(公告)日：2008-05-08
申请号：PCT/US2007/009264
申请日：2007-04-13
申请人： ALZA CORPORATION , WEI, Min , XU, Shuqian , LAM, Andrew, C.
发明人： WEI, Min , XU, Shuqian , LAM, Andrew, C.
CPC分类号： A61K9/146 , A61K9/145 , A61K31/445
摘要： Disclosed is a population of nanoparticles, together with methods of making a population of nanoparticles, wherein one or more of the nanoparticles includes: an amorphous drug core having an effective diameter less than or equal to about 2.0 microns, wherein the amorphous drug core is substantially free of dopant, and wherein the amorphous drug core includes a drug with properties that satisfy the following relationships: a glass transition temperature greater than or equal to about 50 Deg. C, a glass forming ability less than or equal to about 0.85; and water solubility at 25 Deg. C less than or equal to about 1 mg/ml; and at least one stabilizer adsorbed on a surface of the amorphous drug core; and wherein the population of nanoparticles exhibits greater than about six months amorphous stability.
摘要翻译：公开了纳米颗粒群体以及制备纳米颗粒群体的方法，其中一个或多个纳米颗粒包括：具有小于或等于约2.0微米的有效直径的无定形药物核心其中所述无定形药心基本上不含掺杂剂，并且其中所述无定形药心包括具有满足以下关系的性质的药物：玻璃化转变温度大于或等于约50℃。 C，玻璃形成能力小于或等于约0.85; 和在25℃下的水溶性。 C小于或等于约1mg / ml; 和至少一种吸附在无定形药心表面上的稳定剂; 并且其中纳米颗粒群表现出大于约六个月的非晶稳定性。

37. 发明申请

WO2016060908A1 AUTOMATIC INJECTION DEVICE FOR MULTIPLE DOSING 审中-公开
标题翻译：自动注射装置多用量
公开(公告)号：WO2016060908A1
公开(公告)日：2016-04-21
申请号：PCT/US2015/054436
申请日：2015-10-07
申请人： WEI, Min
发明人： WEI, Min
IPC分类号： A61M5/20 , A61M5/32 , A61M5/315
CPC分类号： A61M5/3158 , A61M5/2033 , A61M5/28 , A61M5/31501 , A61M5/31553 , A61M5/31555 , A61M5/31595 , A61M5/3202 , A61M5/3204 , A61M5/3243 , A61M5/3287 , A61M2005/202 , A61M2005/206 , A61M2005/31508
摘要： A medical injection device, including : a medication container having a movable piston; a push rod assembly displaceably disposed in the medical injection device, the push rod assembly having a plurality of spaced-apart position setting means disposed along the length thereof, the push rod assembly selectively displacing the movable piston to dispense medicament from the medication container; a spring to bias the push rod assembly to move toward the distal end of the medical injection device; a releasable restraining means configured to releasably restrain the push rod assembly in a locked state against the biasing of the spring, wherein, upon release of the releasable restraining means, the push rod assembly moves under force of the spring toward the distal end of the medical injection device; and an arming means configured to move the push rod assembly toward the proximal end of the medical injection device.
摘要翻译：一种医疗注射装置，包括：具有活动活塞的药物容器; 所述推杆组件可移动地设置在所述医疗注射装置中，所述推杆组件具有沿其长度设置的多个间隔开的位置设定装置，所述推杆组件选择性地移动所述可移动活塞以从所述药物容器分配药物; 用于偏压推杆组件朝向医疗注射装置的远端移动的弹簧; 可释放限制装置，被配置为可释放地约束推杆组件处于锁定状态以抵抗弹簧的偏置，其中，在释放可释放的约束装置时，推杆组件在弹簧的作用下朝着医疗的远端移动注射装置; 以及布置装置，其构造成使所述推杆组件朝向所述医疗注射装置的近端移动。

38. 发明申请

WO2015199981A1 MEDICATION INFUSION DEVICE 审中-公开
标题翻译：药物输注装置
公开(公告)号：WO2015199981A1
公开(公告)日：2015-12-30
申请号：PCT/US2015/035015
申请日：2015-06-10
申请人： WEI, Min
发明人： WEI, Min
IPC分类号： A61M5/14
CPC分类号： A61M5/14244 , A61M5/14526 , A61M5/158 , A61M5/16804 , A61M5/16877 , A61M2005/14513 , A61M2005/1585
摘要： A wearable infusion device for delivering medication into body of a user, the infusion device comprising a medication container containing a volume of medication to be dispensed; an infusion needle that is fully enclosed in a sterile environment until the infusion needle is inserted into underlying tissue; an infusion needle insertion mechanism associated with the infusion needle, powered by one or more mechanical springs, that when activated, inserts the infusion needle through the skin into underlying tissue; means for delivering medication out of the medication container and into underlying tissue via the infusion needle; and a housing associated with the medication container, the infusion needle, the infusion needle insertion mechanism and the means for delivering medication.
摘要翻译：一种用于将药物输送到使用者身体的可穿戴输注装置，所述输注装置包括容纳待分配的药物量的药物容器; 完全封闭在无菌环境中直到输注针插入下面的组织中的输注针; 与输注针相关联的输注针插入机构，由一个或多个机械弹簧供电，当被激活时，将输注针穿过皮肤插入下面的组织中; 用于将药物从药物容器输送并通过输注针进入下面的组织的装置; 以及与药物容器，输注针，输注针插入机构和用于输送药物的装置相关联的壳体。

39. 发明申请

WO2015138261A1 AUTOMATIC MEDICATION INJECTION DEVICE 审中-公开
标题翻译：自动注射装置
公开(公告)号：WO2015138261A1
公开(公告)日：2015-09-17
申请号：PCT/US2015/019326
申请日：2015-03-07
申请人： WEI, Min
发明人： WEI, Min
IPC分类号： A61M5/20
CPC分类号： A61M5/2033 , A61J1/16 , A61M5/008 , A61M5/3129 , A61M5/3134 , A61M5/3204 , A61M5/326 , A61M5/46 , A61M2005/2013 , A61M2005/2026 , A61M2005/206 , A61M2005/31518 , A61M2005/3258 , A61M2005/3267 , B65B3/003 , B65D1/36 , B65D83/02
摘要： An automatic injection device is provided herein comprising a container body having a distal end and a proximal end; a piston locked at said proximal end of said container body before medication injection; a spring configured to bias said piston distally; a releasable restraining means configured to releasably restrain said piston in a locked state against said biasing of said spring, wherein, upon release of said releasable restraining means, said piston moves under force of said spring toward said distal end of said container body; an activation means configured to release said releasable means; a needle cap placed at said distal end of said container body; and a needle placed at said distal end of said container body.
摘要翻译：本文提供一种自动注射装置，其包括具有远端和近端的容器体; 在注射药物之前，将活塞锁定在所述容器主体的所述近端处; 配置成使所述活塞向远侧偏压的弹簧; 可释放地限制装置，被配置为将所述活塞可释放地限制在锁定状态，以抵抗所述弹簧的所述偏压，其中，当释放所述可释放限制装置时，所述活塞在所述弹簧的作用下朝向所述容器主体的所述远端移动; 配置成释放所述可释放装置的激活装置; 设置在所述容器主体的所述远端的针帽; 以及放置在所述容器主体的所述远端处的针。

40. 发明申请

WO2008002485A3 INCREASED AMORPHOUS STABILITY OF POORLY WATER SOLUBLE DRUGS BY NANOSIZING 审中-公开
公开(公告)号：WO2008002485A3
公开(公告)日：2008-01-03
申请号：PCT/US2007/014585
申请日：2007-06-22
申请人： ALZA CORPORATION , WEI, Min , XU, Shuqian , LAM, Andrew, C.
发明人： WEI, Min , XU, Shuqian , LAM, Andrew, C.
IPC分类号： A61K9/14 , A61K31/00
摘要： Disclosed is a population of nanoparticles, together with methods of making a population of nanoparticles, wherein wherein one or more of the nanoparticles includes: an amorphous drug core having an effective diameter less than or equal to about 2.0 microns, wherein the amorphous drug core is substantially free of dopant, and wherein the amorphous drug core comprises a drug with properties that satisfy the following relationships: a glass transition temperature greater than or equal to about 30 Deg. C; and water solubility at 25 Deg. C less than or equal to about 1 mg/ml; and at least one stabilizer adsorbed on a surface of the amorphous drug core; and wherein the at least one stabilizer is present in an amount effective to provide an amorphous stability of the population of nanoparticles that is approximately equal to or greater than an amorphous stability of an amorphous bulk drug substance comprising the drug, as measured over a period of at least four months.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式